Global Actinic Keratosis Treatment Market by Disease Type (Clinical AK, Subclinical AK), Treatment (Medication, Surgery), End-User - Forecast 2024-2030- Product Image

Sale

Global Actinic Keratosis Treatment Market by Disease Type (Clinical AK, Subclinical AK), Treatment (Medication, Surgery), End-User - Forecast 2024-2030

Report
185 Pages
March 2024
Region: Global
360iResearch™
ID: 5716164

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Actinic Keratosis Treatment Market size was estimated at USD 6.21 billion in 2023, USD 6.48 billion in 2024, and is expected to grow at a CAGR of 4.37% to reach USD 8.38 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Actinic Keratosis Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Actinic Keratosis Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Actinic Keratosis Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Accord Healthcare, Inc., AdipoGen Life Sciences, Almirall, S.A., Athenex, Inc., Bausch Health Companies, Inc., Biofrontera AG, Enzo Life Sciences Inc., Fresenius Kabi, Galderma SA, Glenmark Pharmaceuticals Limited, Hill Dermaceuticals, Inc., LEO Pharma A/S., Merck KGaA, Novartis AG, Perrigo Company PLC, Sagent Pharmaceuticals, Inc., Spear Dermatology Products, Inc., Stanford Chemicals Company, Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Viatris, Inc., and Xiromed LLC.

Market Segmentation & Coverage

This research report categorizes the Actinic Keratosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Disease Type
- Clinical AK
- Subclinical AK
Treatment
- Medication
  - Medicated Cream or Gel
    - Fluorouracil
    - Imiquimod
    - Ingenol Mebutate or Diclofenac
- Surgery
  - Cryotherapy
  - Curettage
  - Laser Therapy
  - Photodynamic Therapy
End-User
- Cancer Treatment Centers
- Homecare
- Hospitals
- Laser Therapy Centers
- Private Dermatology Clinics
- Spas & Rejuvenation Centers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Actinic Keratosis Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Actinic Keratosis Treatment Market?
What are the technology trends and regulatory frameworks in the Actinic Keratosis Treatment Market?
What is the market share of the leading vendors in the Actinic Keratosis Treatment Market?
Which modes and strategic moves are suitable for entering the Actinic Keratosis Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Actinic Keratosis Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of cases of actinic keratosis and skin cancer
5.1.1.2. Growing preference and development of outdoor sports activities
5.1.1.3. Accelerated awareness among consumers for dermatological disease
5.1.2. Restraints
5.1.2.1. Associated adverse health impacts of actinic keratosis treatment
5.1.3. Opportunities
5.1.3.1. Surge in approvals of topical agents and treatment for actinic keratosis
5.1.3.2. Ongoing advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer
5.1.4. Challenges
5.1.4.1. Lack of standardizations for actinic keratosis treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Actinic Keratosis Treatment Market, by Disease Type

6.1. Introduction
6.2. Clinical AK
6.3. Subclinical AK

7. Actinic Keratosis Treatment Market, by Treatment

7.1. Introduction
7.2. Medication
7.3.1. Medicated Cream or Gel
7.3.2.1. Fluorouracil
7.3.2.2. Imiquimod
7.3.2.3. Ingenol Mebutate or Diclofenac
7.3. Surgery
7.4.1. Cryotherapy
7.4.2. Curettage
7.4.3. Laser Therapy
7.4.4. Photodynamic Therapy

8. Actinic Keratosis Treatment Market, by End-User

8.1. Introduction
8.2. Cancer Treatment Centers
8.3. Homecare
8.4. Hospitals
8.5. Laser Therapy Centers
8.6. Private Dermatology Clinics
8.7. Spas & Rejuvenation Centers

9. Americas Actinic Keratosis Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Actinic Keratosis Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Actinic Keratosis Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Accord Healthcare, Inc.
13.1.3. AdipoGen Life Sciences
13.1.4. Almirall, S.A.
13.1.5. Athenex, Inc.
13.1.6. Bausch Health Companies, Inc.
13.1.7. Biofrontera AG
13.1.8. Enzo Life Sciences Inc.
13.1.9. Fresenius Kabi
13.1.10. Galderma SA
13.1.11. Glenmark Pharmaceuticals Limited
13.1.12. Hill Dermaceuticals, Inc.
13.1.13. LEO Pharma A/S.
13.1.14. Merck KGaA
13.1.15. Novartis AG
13.1.16. Perrigo Company PLC
13.1.17. Sagent Pharmaceuticals, Inc.
13.1.18. Spear Dermatology Products, Inc.
13.1.19. Stanford Chemicals Company
13.1.20. Strides Pharma Science Limited
13.1.21. Sun Pharmaceutical Industries Ltd.
13.1.22. Taj Pharmaceuticals Ltd.
13.1.23. Taro Pharmaceutical Industries Ltd.
13.1.24. Viatris, Inc.
13.1.25. Xiromed LLC
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. ACTINIC KERATOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ACTINIC KERATOSIS TREATMENT MARKET DYNAMICS
FIGURE 7. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 8. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 10. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ACTINIC KERATOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 6. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CLINICAL AK, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SUBCLINICAL AK, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 9. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 11. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 13. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY FLUOROURACIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY IMIQUIMOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY INGENOL MEBUTATE OR DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 18. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CURETTAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRIVATE DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SPAS & REJUVENATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 52. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 53. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 81. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 83. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 84. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 85. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 89. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 90. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 91. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 99. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 101. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 102. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 103. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 135. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 136. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 138. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 139. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 157. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 160. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 163. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 164. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 166. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 175. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 176. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 179. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 190. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 191. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 192. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 193. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 194. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 208. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 209. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 214. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 215. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 216. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 217. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 218. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 220. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 221. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 222. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 223. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 224. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 245. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 247. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 248. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 263. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 265. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 266. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 280. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. ACTINIC KERATOSIS TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

3M Company
Accord Healthcare, Inc.
AdipoGen Life Sciences
Almirall, S.A.
Athenex, Inc.
Bausch Health Companies, Inc.
Biofrontera AG
Enzo Life Sciences Inc.
Fresenius Kabi
Galderma SA
Glenmark Pharmaceuticals Limited
Hill Dermaceuticals, Inc.
LEO Pharma A/S.
Merck KGaA
Novartis AG
Perrigo Company PLC
Sagent Pharmaceuticals, Inc.
Spear Dermatology Products, Inc.
Stanford Chemicals Company
Strides Pharma Science Limited
Sun Pharmaceutical Industries Ltd.
Taj Pharmaceuticals Ltd.
Taro Pharmaceutical Industries Ltd.
Viatris, Inc.
Xiromed LLC

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 6.48 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.38 Billion
Compound Annual Growth Rate	4.3%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Actinic Keratosis Treatment Global Market Report 2024

Actinic Keratosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Actinic Keratosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Actinic Keratosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

About the Actinic Keratosis Drug Market